Esoprim S.K. 40 mg indicated in adults for:
Gastroesophageal Reflux Disease (GERD)- treatment of erosive reflux esophagitis – long-term management of patients with healed esophagitis to prevent relapse – symptomatic treatment of gastroesophageal reflux disease. In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori and- healing of Helicobacter pylori associated duodenal ulcer and prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers -Patients requiring continued NSAID therapy Healing of gastric ulcers associated with NSAID therapy.
- Prevention of gastric and duodenal ulcers associated with NSAID therapy in patients at risk.
- Prolonged treatment after i.v. Induced prevention of rebleeding of peptic ulcers. Esoprim S.K 20 mg is indicated in adolescents from the age of 12 years for: Gastro-esophageal Reflux Disease (GERD) – treatment of erosive reflux esophagitis -long-term management of patients with healed esophagitis to prevent relapse-symptomatic treatment of gastro-esophageal reflux disease. In combination with antibiotics in the treatment of duodenal ulcer caused by Helicobacter pylori.
**Disclaimer:
The images and designs presented on this website are for illustrative purposes only. Actual products may differ from those shown, including variations in color, packaging design, wording, or other visual features. The company assumes no responsibility for any such discrepancies and does not undertake to update the website to reflect changes in the actual product.
*** Disclaimer
The information provided herein is not intended as medical advice and must not be relied upon for diagnosis, treatment, or the provision of medical care. It does not replace the official prescribing/patient leaflet or consultation with a qualified healthcare professional. Before any use, always review the official physician/patient leaflet and consult a licensed physician. The company assumes no responsibility or liability for any reliance placed on the information presented on this page.
